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etymologia
Coxiella [kok′′ se-el′ ə] burnetii
Etiologic agent of Q fever, named after American bacteriologist Herald Rea Cox and Australian physician Frank 
MacFarlane Burnet, who both independently isolated the bacterium in the 1930s. C. burnetii belongs in the family 
Coxiellaceae, which consists of gram-negative rods without fl agella or a capsule. The bacteria occur in ticks and 
various vertebrates, including humans.
Source: Dorland’s illustrated medical dictionary, 31st edition. Philadelphia: Saunders; 2007; American Veterinary Medical Association. 
Q fever backgrounder. Available from http://www.avma.org/public_health/biosecurity/qfever_bgnd.asp
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